These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 27365492

  • 1. Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis.
    Canvin M, Sinka K, Hughes G, Mesher D.
    Sex Transm Infect; 2017 Mar; 93(2):125-128. PubMed ID: 27365492
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18.
    Chow EPF, Carter A, Vickers T, Fairley CK, McNulty A, Guy RJ, Regan DG, Grulich AE, Callander D, Khawar L, Machalek DA, Donovan B.
    Lancet Infect Dis; 2021 Dec; 21(12):1747-1756. PubMed ID: 34339639
    [Abstract] [Full Text] [Related]

  • 6. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
    Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Guy RJ.
    BMJ; 2013 Apr 18; 346():f2032. PubMed ID: 23599298
    [Abstract] [Full Text] [Related]

  • 7. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
    Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK.
    Lancet Infect Dis; 2011 Jan 18; 11(1):39-44. PubMed ID: 21067976
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB, Legler A, Hanchate A.
    Sex Transm Dis; 2015 Dec 18; 42(12):665-8. PubMed ID: 26562694
    [Abstract] [Full Text] [Related]

  • 12. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
    Denecke A, Iftner T, Iftner A, Riedle S, Ocak M, Luyten A, Üye I, Tunc K, Petry KU.
    BMC Infect Dis; 2021 Jul 02; 21(1):634. PubMed ID: 34215215
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology of genital warts in the British population: implications for HPV vaccination programmes.
    Sonnenberg P, Tanton C, Mesher D, King E, Beddows S, Field N, Mercer CH, Soldan K, Johnson AM.
    Sex Transm Infect; 2019 Aug 02; 95(5):386-390. PubMed ID: 30723185
    [Abstract] [Full Text] [Related]

  • 14. Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States.
    Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE.
    Vaccine; 2013 Aug 20; 31(37):3899-905. PubMed ID: 23820080
    [Abstract] [Full Text] [Related]

  • 15. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
    Woestenberg PJ, King AJ, van der Sande MA, Donken R, Leussink S, van der Klis FR, Hoebe CJ, Bogaards JA, van Benthem BH, Medical Microbiological Laboratories, Public Health Services.
    J Infect; 2017 Apr 20; 74(4):393-400. PubMed ID: 28126492
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation.
    Szarewski A, Skinner SR, Garland SM, Romanowski B, Schwarz TF, Apter D, Chow SN, Paavonen J, Del Rosario-Raymundo MR, Teixeira JC, De Carvalho NS, Castro-Sanchez M, Castellsagué X, Poppe WA, De Sutter P, Huh W, Chatterjee A, Tjalma WA, Ackerman RT, Martens M, Papp KA, Bajo-Arenas J, Harper DM, Torné A, David MP, Struyf F, Lehtinen M, Dubin G.
    J Infect Dis; 2013 Nov 01; 208(9):1391-6. PubMed ID: 24092907
    [Abstract] [Full Text] [Related]

  • 17. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
    Dominiak-Felden G, Gobbo C, Simondon F.
    PLoS One; 2015 Nov 01; 10(7):e0132404. PubMed ID: 26147096
    [Abstract] [Full Text] [Related]

  • 18. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.
    Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw CS.
    Sex Transm Infect; 2009 Dec 01; 85(7):499-502. PubMed ID: 19837728
    [Abstract] [Full Text] [Related]

  • 19. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM, Heywood A, Heley S.
    Sex Health; 2009 Sep 01; 6(3):178-84. PubMed ID: 19653953
    [Abstract] [Full Text] [Related]

  • 20. Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations.
    Camenga DR, Dunne EF, Desai MM, Gee J, Markowitz LE, Desiliva A, Klein NP.
    Sex Transm Dis; 2013 Jul 01; 40(7):534-8. PubMed ID: 23965766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.